ABBV
AbbVie Inc.
Stock
$263.29−2.99 (−1.12%)Close Sep 29, 2026
| Research and development (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $9.7B | −25.9% | 7.4% | 7.8% |
| Research and development (TTM) | $9.7B |
|---|---|
| YoY | −25.9% |
| 5-year CAGR | 7.4% |
| 10-year CAGR | 7.8% |
Research and development
| Period | R&D | YoY |
|---|---|---|
| 2025 | $9.1B | −28.9% |
| 2024 | $12.8B | +66.7% |
| 2023 | $7.7B | +17.9% |
| 2022 | $6.5B | −6.0% |
| 2021 | $6.9B | +8.5% |
| 2020 | $6.4B | −0.4% |
| 2019 | $6.4B | −38.0% |
| 2018 | $10.3B | +106.3% |
| 2017 | $5.0B | +14.2% |
| 2016 | $4.4B | +2.3% |
| 2015 | $4.3B | +30.0% |
| 2014 | $3.3B | +15.5% |
| 2013 | $2.9B | +2.8% |
| 2012 | $2.8B | +6.1% |
| 2011 | $2.6B | — |